✦ LIBER ✦

The Impact of the Orphan Drug Act on the Development and Advancement of Neurological Products for Rare Diseases: A Descriptive Review

✍ Scribed by Burke, K A; Freeman, S N; Imoisili, M A; Coté, T R

Book ID: 109846083
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 105 KB
Volume: 88
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.2010.193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phenylketonuria as a model for protein m

Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism

✍ Ania C. Muntau; Søren W. Gersting 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 520 KB

A review and commentary on a sample of 1

A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease

✍ Richard J. Harvey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

Background. There has been widespread development of clinical guidelines for the treatment of Alzheimer's disease since the introduction of donepezil in the UK in 1997. These have been developed nationally, regionally, locally and by independent groups. An independent review of guidelines available

Review on the development of a hybrid in

Review on the development of a hybrid incremental sheet forming system for small batch sizes and individualized production

✍ B. Taleb Araghi; A. Göttmann; M. Bambach; G. Hirt; G. Bergweiler; J. Diettrich; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 951 KB

Current status and predicted impact of c

Current status and predicted impact of climate change on forest production and biogeochemistry in the temperate oceanic European zone: review and prospects for Belgium as a case study

✍ Matteo Campioli; Caroline Vincke; Mathieu Jonard; Vincent Kint; Gaston Demarée; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 551 KB